Antibiotics
| Catalog | Product Name / CAS / Description | Structure |
|---|---|---|
| BBF-03286 |
Tetranolin (132074-82-9) Inquiry |
|
Tetranolin is a lactone antibiotic produced by Act. sp. SS-1018. It has anti-Gram-positive bacteria activity and weak anti-mycobacterial activity. |
||
| BBF-03287 | ||
APD-I is an ester peptide antibiotic produced by Bacillus subtilis C-756. It can inhibit the activity of cyclic-AMP phosphodiesterase. |
||
| BBF-03288 | ||
APD-II is an ester peptide antibiotic produced by Bacillus subtilis C-756. It can inhibit the activity of cyclic-AMP phosphodiesterase. |
||
| BBF-03289 | ||
APD-III is an ester peptide antibiotic produced by Bacillus subtilis C-756. It can inhibit the activity of cyclic-AMP phosphodiesterase. |
||
| BBF-03290 |
Pimprinethine (146426-35-9) Inquiry |
|
Pimprinethine is a pyrazoloisoquinolinone antibiotic produced by Streptoverticillium griseocarneum. It has weak anti-Gram-positive bacteria activity. |
||
| BBF-03291 | ||
APHE-2 is a pyrazoloisoquinolinone antibiotic produced by Streptoverticillium griseocarneum. It has weak anti-Gram-positive bacteria activity. |
||
| BBF-03292 | ||
APHE-4 is a pyrazoloisoquinolinone antibiotic produced by Streptoverticillium griseocarneum. It has weak anti-Gram-positive bacteria activity. |
||
| BBF-03293 | ||
NK-1013-1 is an aminoglycoside antibiotic isolated from Streptomyces kanamyceticus var.21-16. It is active against gram-positive bacteria. |
||
| BBF-03294 | ||
NK-1013-2 is an aminoglycoside antibiotic isolated from Streptomyces kanamyceticus var.21-16. It is active against gram-positive and gram-negative bacteria. |
||
| BBF-03296 |
NK 154183A (152986-47-5) Inquiry |
|
NK 154183A is a 24-membered macrolide antibiotic isolated from the fermentation broth of Streptomyces sp. NK154183. It exhibits antifungal and antitumor activity against the human colon adenocarcinoma. |
||
| BBF-03297 |
NK 154183B (152986-49-7) Inquiry |
|
NK 154183B is a 24-membered macrolide antibiotic isolated from the fermentation broth of Streptomyces sp. NK154183. It exhibits antifungal and antitumor activity against the human colon adenocarcinoma. |
||
| BBF-03301 | ||
No. 17927 D is a beta-lactam antibiotic produced by Streptomyces fulvoviridis SANK 61278, SANK 60183 and SANK 69283. The antibacterial activity is weak. |
||
| BBF-03303 | ||
NS-5 is a beta-lactam antibiotic produced by Streptomyces cattaleya. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. |
||
| BBF-03306 | ||
OA-6129 A is a carbapenem antibiotic produced by Streptomyces sp. OA-6129. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. |
||
| BBF-03307 | ||
OA-6129 B1 is a carbapenem antibiotic produced by Streptomyces sp. OA-6129. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. |
||
| BBF-03308 |
OA-6129 B2 (82475-10-3) Inquiry |
|
OA-6129 B2 is a carbapenem antibiotic produced by Streptomyces sp. OA-6129. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. |
||
| BBF-03309 | ||
OA-6129 C is a carbapenem antibiotic produced by Streptomyces sp. OA-6129. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. |
||
| BBF-03310 | ||
OA-6129 D is a carbapenem antibiotic produced by Streptomyces sp. OA-6129. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. It is also effective against dehydrodipeptidase and Comamonas terrigena B-996. |
||
| BBF-03311 | ||
OA-6129 E is a carbapenem antibiotic produced by Streptomyces sp. OA-6129. It inhibits gram-positive, gram-negative bacteria and beta-lactamase. It is also effective against dehydrodipeptidase and Comamonas terrigena B-996. |
||
| BBF-03316 | ||
OM-173αE is a quinone bacterial metabolite originally isolated from Streptomyces hebeiensis, displaying antimicrobial activity. It is effective against mycoplasma and fungus. |
